secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001214659-25-011357
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro issues 243,429 common shares on conversion of Series B Preferred (Jul 23-30, 2025)
--------------------------------------------------------------------------------

- 243,429 common shares issued upon conversion of ~564.76 shares of Series B Convertible Preferred Stock.
- Total common outstanding as of July 30, 2025: 3,139,861 shares.
- Issuance made in reliance on Section 4(a)(2) exemption from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925011357/0001214659-25-011357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925011357/i812508k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-011357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer